Indications and uses
controls the symptom of: dandruff seborrheic dermatitis psoriasis
controls the symptom of: dandruff seborrheic dermatitis psoriasis
for best results use at least twice a week or as directed by a doctor. wet hair thoroughly. massage shampoo into the scalp. lather, leave on hair and scalp for several minutes. rinse and repeat.
store at room temperature store away from direct sunlight.
Drug Facts
Salicylic acid 3.0%
Anti-dandruff, anti-seborrheic dermatitis, anti-psoriasis
controls the symptom of:
For external use only.
Ask a doctor before use if you have a condition that covers a large area of the body.
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
water, sodium C14-16 olefin sulfonate, cocamidopropyl betaine, cocamide MIPA, PEG-150 distearate, polyquaternium-10, propylene glycol, sodium citrate, fragrance, sodium hydroxide.
1-866-567-8600
Dist. by Target Corporation
Minneapolis, MN 55403
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| dea2eded-d1e7-46bb-9a3d-f8dc20de6277 | Product name | 1 | 20190408 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 82442-743-01 | upandup Anti-dandruff with Salicylic AcidAnti-dandruff, anti-seborrheic dermatitis, anti-psoriasis | 355 mL in 1 BOTTLE | SHAMPOO | 355 | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 82442-743 | 82442-743-01 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| upandup Anti-dandruff with Salicylic Acid Anti-dandruff, anti-seborrheic dermatitis, anti-psoriasis | SALICYLIC ACID | TARGET CORPORATION | 482332f8-0db4-4ec7-81e9-c4efbba16a26 | 2024-05-20 | Warnings | 82442-743-01 82442-743 82442074301 a695a5c6-ca60-4434-be5c-317f32878e9c 482332f8-0db4-4ec7-81e9-c4efbba16a26 |
Adverse event summaries are temporarily unavailable. Other product information remains available.